Latest News
Ocular Therapeutix, Inc.
- Ocular Therapeutix, Inc. Estimates – NASDAQ:OCUL
- Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Win
- Ocular Therapeutix at chardan healthcare conference: wet amd push advances
- Ocular Therapeutix stock hits 52-week low at 6.23 USD By Investing.com
- Ocular Therapeutix stock hits 52-week low at 6.23 USD By Investing.com
- Sanjay Nayak resigns as Chief Strategy Officer at Ocular Therapeutix
- OCULAR THERAPEUTIX, INC. Announces Resignation of Sanjay Nayak as Chief Strategy Officer, Effective October 16, 2026
- Ocular Therapeutix, Inc. (OCUL) Presents at American Academy of Ophthalmology Retina Subspeciality Day - Slideshow (NASDAQ:OCUL) 2026-10-15
- Form 144 OCULAR THERAPEUTIX For: 10 October By Investing.com
- Form 144 OCULAR THERAPEUTIX For: 10 October By Investing.com
- Form 4 Ocular Therapeutix Inc For: 6 October By Investing.com
- RBC Capital reiterates Ocular Therapeutix stock rating on wAMD treatment potential
Headlines from the last 30 days, linking to the original publishers. See all market news →